Part 11 Audit Trails, Legacy Systems Subject To FDA Enforcement Discretion
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers must continue to validate electronic recordkeeping and signature systems under ongoing FDA part 11 enforcement discretion, according to CDRH International Staff Director Christine Nelson